Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96GY0
UPID:
ZC21A_HUMAN
Alternative names:
-
Alternative UPACC:
Q96GY0; Q9Y372
Background:
Zinc finger C2HC domain-containing protein 1A, identified by the accession number Q96GY0, is a protein of interest in the field of molecular biology. Its structure, characterized by the presence of a zinc finger C2HC domain, suggests a role in DNA binding, transcriptional regulation, or RNA processing, common functions among proteins with similar domains.
Therapeutic significance:
Understanding the role of Zinc finger C2HC domain-containing protein 1A could open doors to potential therapeutic strategies. Its involvement in fundamental cellular processes makes it a candidate for further research in disease mechanisms and drug discovery.